FDA Approved: PREGABALIN — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for pregabalin submitted by Mylan Pharmaceuticals Inc., updating the regulatory status of the product in the U.S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Fibromyalgia
• Partial-onset Seizures
• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)